Deferred Income Tax Expense (Benefit) of Xeris Biopharma Holdings, Inc. from 31 Dec 2021 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.
Summary
Xeris Biopharma Holdings, Inc. annual and quarterly Deferred Income Tax Expense (Benefit) in USD history and change rate from 31 Dec 2021 to 31 Dec 2025.
  • Xeris Biopharma Holdings, Inc. Deferred Income Tax Expense (Benefit) for the quarter ending 31 Mar 2025 was $0, a 100% decline year-over-year.
  • Xeris Biopharma Holdings, Inc. annual Deferred Income Tax Expense (Benefit) for 2025 was $0.
  • Xeris Biopharma Holdings, Inc. annual Deferred Income Tax Expense (Benefit) for 2024 was $2,268,000, a 82% decline from 2023.
  • Xeris Biopharma Holdings, Inc. annual Deferred Income Tax Expense (Benefit) for 2023 was $1,249,000, a 12% increase from 2022.
Source SEC data
View on sec.gov
Deferred Income Tax Expense (Benefit), Annual (USD)
Deferred Income Tax Expense (Benefit), YoY Annual Change (%)
Deferred Income Tax Expense (Benefit), Quarterly (USD)
Deferred Income Tax Expense (Benefit), YoY Quarterly Change (%)

Xeris Biopharma Holdings, Inc. Annual Deferred Income Tax Expense (Benefit) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $0 +$2,268,000 01 Jan 2025 31 Dec 2025 10-K 02 Mar 2026 2025 FY
2024 $2,268,000 -$1,019,000 -82% 01 Jan 2024 31 Dec 2024 10-K 02 Mar 2026 2025 FY
2023 $1,249,000 +$175,000 +12% 01 Jan 2023 31 Dec 2023 10-K 02 Mar 2026 2025 FY
2022 $1,424,000 -$1,424,000 01 Jan 2022 31 Dec 2022 10-K 06 Mar 2025 2024 FY
2021 $0 01 Jan 2021 31 Dec 2021 10-K 06 Mar 2024 2023 FY

Xeris Biopharma Holdings, Inc. Quarterly Deferred Income Tax Expense (Benefit) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $0 -$307,000 -100% 01 Jan 2025 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q1 2024 $307,000 +$307,000 01 Jan 2024 31 Mar 2024 10-Q 08 May 2025 2025 Q1
Q1 2023 $0 01 Jan 2023 31 Mar 2023 10-Q 09 May 2024 2024 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.